部分発作が十分にコントロールされていない小児におけるTRI476（オクスカルバゼピン）の長期安全性および忍容性

基本情報

NCT ID: NCT01051193
ステータス: 完了
試験のフェーズ: 第2/第3相
試験タイプ: 介入
目標被験者数: 88
治験依頼者名: Nobelpharma

概要

This study is designed to provide long term safety data of TRI476 in children with inadequately-controlled partial seizures. This study is conducted in patients who complete the core study CTRI476B1301. Blinding is maintained during the transition and dose adjustment phase of the extension study. All patients are treated with TRI476 from the dose adjustment phase onwards. The purpose of study is to confirm that TRI476 as adjunctive therapy is safe.

対象疾患

Partial Onset Seizures

介入

Oxcarbazepine(DRUG)

依頼者（Sponsor）

Nobelpharma(INDUSTRY)